This week, we reported that bioplastics maker Avantium is planning an initial public offering and listing of all shares on Euronext Amsterdam and Euronext Brussels. The company expects to raise up to €100 million (USD$106 million) and complete the offering by the end of the current quarter. More than half of the offering has already been secured via commitments from cornerstone investors.
Before the “quirt period” Cone of Silence descended, CEO Tom Van Aken gave this illuminating overview of the company’s technology, progress and prospects at ABLC.
